Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Decreases Acinetobacter baumannii PR07 - : ceftazidime |
👶
In vitro activity of cefiderocol and comparator antibiotics against multidrug-resistant non-fermenting Gram-negative bacilli. JAC-antimicrobial resistance (JAC Antimicrob Resist ) Vol: 6 Issue 1 Pages: dlae006 Pub: 2024 Feb Epub: 2024 Feb 1 Authors Huang YS , Chuang YC , Chen PY , Chou PC , Wang JT , Html Article Publication |
Decreases Acinetobacter baumannii PR07 - : ceftazidime |
👶
Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chinese medical journal (Chin Med J (Engl) ) Vol: 126 Issue 12 Pages: 2207-14 Pub: 2013 Jun Epub: Authors Ye F , He LX , Cai BQ , Wen FQ , Chen BY , Hadiarto M , Chen RC , Yuan JP , Sun HL , |
Decreases Acinetobacter baumannii PR07 - : ceftazidime |
👶
Phage-derived polysaccharide depolymerase potentiates ceftazidime efficacy against Acinetobacter baumannii pneumonia via low-serum-dependent mechanisms. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 282 Issue Pt 6 Pages: 137486 Pub: 2024 Nov 9 Epub: 2024 Nov 9 Authors Wang H , Zeng P , Zhang P , Zuo Z , Liu Y , Xia J , Lam JKW , Chan HK , Leung SSY , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]